Drug Shortage Report for AURO-OLMESARTAN
Report ID | 199665 |
Drug Identification Number | 02443864 |
Brand name | AURO-OLMESARTAN |
Common or Proper name | OLMESARTAN |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | OLMESARTAN MEDOXOMIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100's |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-07-21 |
Estimated end date | 2024-05-31 |
Actual end date | 2024-05-30 |
Shortage status | Resolved |
Updated date | 2024-05-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.